NILM

AcronymDefinition
NILMNon-Intrusive Load Monitor
NILMNational Interest Land Mass (Canada)
NILMNegative for Intraepithelial Lesion and Malignancy
NILMNot in Left Message
References in periodicals archive ?
Pap Smear Finding according to Bethesda Classification Diagnosis Number of Patients Percentage (%) Inadequate 35 5 NILM Normal 107 15.
Adenocarcinoma in situ was more frequently interpreted as atrophic vaginitis on SurePath than on ThinPrep slides, but less frequently interpreted as NILM or reparative changes (Table 3).
INK4[alfa]]/ Ki-67 Negativo Positivo Negativa Positiva NILM (n = 11) 2 (18,0%) 9 (81,8%) 11 (100,0%) 0 ASC-US (n = 32) 14 (44,0%) 18 (56,0%) 24 (75,0%) 8 (25,0%) LSIL (n = 62) 4 (6,5%) 58 (93,5%) 35 (56,5%) 27 (44,0%) HSIL (n = 10) 1 (10,0%) 9 (90,0%) 3 (30,0%) 7 (70,0%) Total (n = 115) 21 (18,3%) 94 (81,7%) 73 (63,5%) 42 (36,5%) NILM: negativa para lesion intraepitelial o malignidad.
Currently, residential buildings account for as much as 37 pc of the total electricity use in the United States, so a system such as NILM, which provides continuous monitoring could make households greener as well as more cost effective.
Other cases included NILM (12 cases), TV (1 case), BV (3 cases), atrophic (2 case), HPV (1 case), LSIL (2 cases) and HSIL (cases).
35%) Table 3: Shows Age-wise Distribution of Smear of NILM Nonspecific Trichomonas Years Inflammatory Vaginalis Candidiasis Smear 21-30 315 (20.
The discordance scores were determined as follows: 0 for AGC-favor neoplasia and above, 0 for HSIL if histologic HSIL (cervical intraepithelial neoplasia 2/3) was also present in the tissue biopsy, 1 for AGC not otherwise specified or HSIL without a histologic HSIL present, 2 for LSIL, 3 for ASCUS, and 4 for NILM.
In present study of LBC cervical smear the most common lesion in NILM category was inflammatory smear+- reactive changes (50.
8% Table 2: Cytological findings of 12698 cases Diagnosis Number of cases Percentage NILM 12175 95.
44%) were NILM (Negative for Intraepithelial Lesion or Malignancy) and 116 (18.
Forty slides (ThinPrep; Hologic, Marlborough, Massachusetts) were selected that had been originally interpreted as NILM from a laboratory with a pool of 14 cytotechnologists.
We also calculated the false-positive rate (for a category D, HSIL+, response to a category B, negative reference diagnosis) for the 3 participant types, for both pre-PT and PT, and for each of the specific reference diagnoses in the negative category (100 series): NILM, not otherwise specified; fungal organisms consistent with Candida spp; Trichomonas vaginalis; cellular changes consistent with HSV; reparative changes; atrophic vaginitis; and follicular cervicitis (Table 4).